Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G S Gray

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Cancer Research|October 16, 1999
Potent activity of soluble B7-IgG fusion proteins in therapy of established tumors and as vaccine adjuvantK Sturmhoefel, K Lee, G S Gray, et al.
Clinical Immunology (Orlando, Fla.)|September 10, 1999
Immune response enhancement by in vivo administration of B7.2Ig, a soluble costimulatory proteinH Swiniarski, K Sturmhoefel, K Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1996
Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cellsB R Blazar, A H Sharpe, P A Taylor, et al.
International Immunology|June 1, 1997
The IgV domain of human B7-2 (CD86) is sufficient to co-stimulate T lymphocytes and induce cytokine secretionP Rennert, K Furlong, C Jellis, et al.
Protein Expression and Purification|April 1, 1991
Expression and purification of active recombinant platelet factor 4 from a cleavable fusion proteinJ A Myers, G S Gray, D J Peters, et al.
Immunity|September 1, 1994
Absence of B7-dependent responses in CD28-deficient miceJ M Green, P J Noel, A I Sperling, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1993
Expression and functional significance of an additional ligand for CTLA-4D J Lenschow, G H Su, L A Zuckerman, et al.
Journal of Neuroimmunology|March 1, 1996
Opposing effects of CTLA4-Ig and anti-CD80 (B7-1) plus anti-CD86 (B7-2) on experimental allergic encephalomyelitisP J Perrin, D Scott, T A Davis, et al.
Blood|May 1, 1997
The role of B7 costimulation by murine acute myeloid leukemia in the generation and function of a CD8+ T-cell line with potent in vivo graft-versus-leukemia propertiesM W Boyer, D A Vallera, P A Taylor, et al.
Science (New York, N.Y.)|January 5, 1990
Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptidesT E Maione, G S Gray, J Petro, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Cancer Research|October 16, 1999
Potent activity of soluble B7-IgG fusion proteins in therapy of established tumors and as vaccine adjuvantK Sturmhoefel, K Lee, G S Gray, et al.
Clinical Immunology (Orlando, Fla.)|September 10, 1999
Immune response enhancement by in vivo administration of B7.2Ig, a soluble costimulatory proteinH Swiniarski, K Sturmhoefel, K Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1996
Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cellsB R Blazar, A H Sharpe, P A Taylor, et al.
International Immunology|June 1, 1997
The IgV domain of human B7-2 (CD86) is sufficient to co-stimulate T lymphocytes and induce cytokine secretionP Rennert, K Furlong, C Jellis, et al.
Protein Expression and Purification|April 1, 1991
Expression and purification of active recombinant platelet factor 4 from a cleavable fusion proteinJ A Myers, G S Gray, D J Peters, et al.
Immunity|September 1, 1994
Absence of B7-dependent responses in CD28-deficient miceJ M Green, P J Noel, A I Sperling, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1993
Expression and functional significance of an additional ligand for CTLA-4D J Lenschow, G H Su, L A Zuckerman, et al.
Journal of Neuroimmunology|March 1, 1996
Opposing effects of CTLA4-Ig and anti-CD80 (B7-1) plus anti-CD86 (B7-2) on experimental allergic encephalomyelitisP J Perrin, D Scott, T A Davis, et al.
Blood|May 1, 1997
The role of B7 costimulation by murine acute myeloid leukemia in the generation and function of a CD8+ T-cell line with potent in vivo graft-versus-leukemia propertiesM W Boyer, D A Vallera, P A Taylor, et al.
Science (New York, N.Y.)|January 5, 1990
Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptidesT E Maione, G S Gray, J Petro, et al.
Pageof 6